Cidre-Aranaz, F., Grünewald, T. G. P., Surdez, D., Garcia-Garcia, L., Carlos Lázaro, J., Kirchner, T., . . . Alonso, J. (2017). EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.
Citación estilo ChicagoCidre-Aranaz, Florencia, et al. EWS-FLI1-mediated Suppression of the RAS-antagonist Sprouty 1 (SPRY1) Confers Aggressiveness to Ewing Sarcoma. 2017.
Cita MLACidre-Aranaz, Florencia, et al. EWS-FLI1-mediated Suppression of the RAS-antagonist Sprouty 1 (SPRY1) Confers Aggressiveness to Ewing Sarcoma. 2017.
Precaución: Estas citas no son 100% exactas.